What is NDC 60760-063?

60760-063 is the product NDC for Lisinopril And Hydrochlorothiazide, Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1 tablet, listed with the FDA by St Marys Medical Park Pharmacy. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Hydrochlorothiazide, Lisinopril.

St Marys Medical Park Pharmacy, NDC labeler code 60760. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lisinopril And Hydrochlorothiazide?

86 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lisinopril And Hydrochlorothiazide NDC 60760-063

NDC codes

FDA NDC Directory

Product NDC (as listed)60760-063Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60760-0063Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60760-063-90	60760006390	90 TABLET in 1 BOTTLE, PLASTIC (60760-063-90)Marketed from Mar 9, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lisinopril And Hydrochlorothiazide
Generic name (nonproprietary): lisinopril and hydrochlorothiazide
Active ingredients: Hydrochlorothiazide — 12.5 mg/1Lisinopril — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: St Marys Medical Park PharmacyNDC labeler code 60760
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077912
Marketing start: May 16, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 60760-063_4c9999f7-5ebf-2921-e063-6294a90aae56SPL ID 4c9999f7-5ebf-2921-e063-6294a90aae56SPL set ID e7b68ea6-4fc8-441a-9640-1ccd3a482d8eRxCUI 197885UNII 0J48LPH2TH, E7199S1YWR
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460760006390 followed by a unit qualifier and the quantity

Package 60760-0063-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 9, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lisinopril and hydrochlorothiazide tablets USP are indicated for the treatment of hypertension. These fixed-dose combinations are not indicated for initial therapy (see DOSAGE AND ADMINISTRATION ). In using lisinopril and hydrochlorothiazide tablets USP, consideration should be given to the fact that an angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that lisinopril does not have a similar risk. (See WARNINGS .) In considering use of lisinopril and hydrochlorothiazide tablets USP, it should be noted that Black pati…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60760-063

What is NDC 60760-063?: 60760-063 is the product NDC for Lisinopril And Hydrochlorothiazide, Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1 tablet, listed with the FDA by St Marys Medical Park Pharmacy. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lisinopril And Hydrochlorothiazide.
What is the active ingredient?: Hydrochlorothiazide, Lisinopril.
Who is the labeler?: St Marys Medical Park Pharmacy, NDC labeler code 60760. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lisinopril And Hydrochlorothiazide?: 86 other product NDCs are listed under this name. See all Lisinopril And Hydrochlorothiazide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lisinopril And Hydrochlorothiazide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Coupler LLC	67046-0433	67046-0433-03
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4516	70518-4516-0070518-4516-01
LISINOPRIL and HYDROCHLOROTHIAZIDE	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	GSMS, Incorporated	51407-564	51407-0564-0551407-0564-90
LISINOPRIL and HYDROCHLOROTHIAZIDE	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	GSMS, Incorporated	51407-565	51407-0565-0551407-0565-90
LISINOPRIL and HYDROCHLOROTHIAZIDE	Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	GSMS, Incorporated	51407-566	51407-0566-0551407-0566-90
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-586	60760-0586-90
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0207	80425-0207-03
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8253	68788-8253-0168788-8253-0368788-8253-06+1 more
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8224	68788-8224-0168788-8224-0368788-8224-06+1 more
Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets	Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-3505	70518-3505-0070518-3505-0170518-3505-04

All 87 Lisinopril And Hydrochlorothiazide NDCs

Other NDCs under ANDA 077912

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077912
Product	Strength	Form · route	Labeler	Product NDC
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	QPharma, Inc.	42708-150
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-458
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-468
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-482
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	A-S Medication Solutions	50090-2565
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	A-S Medication Solutions	50090-2974
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	A-S Medication Solutions	50090-6976
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	A-S Medication Solutions	50090-7751
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Northwind Health Company, LLC	51655-311
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Northwind Health Company, LLC	51655-412
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	Northwind Health Company, LLC	51655-413
Lisinopril And Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Proficient Rx LP	63187-319
Lisinopril And Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	Proficient Rx LP	63187-467
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	Bryant Ranch Prepack	63629-3739
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Bryant Ranch Prepack	63629-4470
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	Coupler LLC	67046-0433
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1; Lisinopril 20 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-1945
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2183
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 20 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-3177
Lisinopril and Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1; Lisinopril 10 mg/1	TabletOral	Lupin Pharmaceuticals, Inc.	68180-518

Showing 20 of 34.